Strategies for Expediting Clinical Trials in the Next Public Health Emergency

TY - JOUR

T1 - Strategies for Expediting Clinical Trials in the Next Public Health Emergency

AU - Titanji, Boghuma K.

AU - Boulware, David R.

AU - Bender Ignacio, Rachel A.

N1 - Funding Information: Conflict of Interest Disclosures: Dr Titanji reported grants from the Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) program (75% salary support) and Emory Center for AIDS Research (research and salary support) during the submitted work. Dr Boulware reported serving as trial steering committee cochair for the National Institutes of Health ACTIV-6 trial focused on assessing repurposed outpatient COVID-19 therapies. Dr Bender Ignacio reported grants from National Institutes of Health; research funding through institution from Novartis, Enanta Pharmaceuticals, Ascentage Pharma; and personal fees (consulting) from Resverlogix outside the submitted work.

PY - 2023/9/29

Y1 - 2023/9/29

UR - https://www.scopus.com/pages/publications/85172827779

UR - https://www.scopus.com/pages/publications/85172827779#tab=citedBy

U2 - 10.1001/jamahealthforum.2023.3191

DO - 10.1001/jamahealthforum.2023.3191

M3 - Short survey

C2 - 37773506

AN - SCOPUS:85172827779

SN - 2689-0186

VL - 4

SP - E233191

JO - JAMA Health Forum

JF - JAMA Health Forum

IS - 9

ER -